US Pharma MarketingSalk Institute’s president on NIH cuts, being ‘all in’ on AI, and the Year of the Brain
Highlights from a sitdown interview with Salk Institute President Gerald Joyce on NIH tumult, AI and the future of basic research. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The push for…
SAN DIEGO — From the president’s office at the Salk Institute, Gerald Joyce has a quintessential California view of hang gliders soaring over the Pacific Ocean.
It’s been a little more turbulent for US research centers ...
Source: Endpoints News